Bank Of New York Mellon Corp Compass Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$3.14 - $5.48 $123,420 - $215,396
39,306 New
39,306 $129 Million
Q4 2022

Feb 14, 2023
BUY
$2.55 - $5.41 $100,230 - $212,645
39,306 New
39,306 $197,000
Q3 2022

Nov 14, 2022
BUY
$1.9 - $3.37 $46,076 - $81,725
24,251 New
24,251 $55,000

Others Institutions Holding CMPX

# of Institutions
80
Shares Held
92M
Call Options Held
0
Put Options Held
0
View Full List

About Compass Therapeutics, Inc.

CMPX Quotes by TradingView
  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $161M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email